Menu
Back to User profile » Dr Virote Sriuranpong
Papers published by Dr Virote Sriuranpong:
Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey.
Ou SI, Le X, Nagasaka M, Reungwetwattana T, Ahn MJ, Lim DW, Santos ES, Shum E, Lau SC, Lee JB, Calles A, Wu F, Lopes G, Sriuranpong V, Tanizaki J, Horinouchi H, Garassino MC, Popat S, Besse B, Rosell R, Soo RA
Lung Cancer: Targets and Therapy 2024, 15:87-114
Published Date: 22 June 2024
Everolimus for the treatment of advanced gastrointestinal or lung nonfunctional neuroendocrine tumors in East Asian patients: a subgroup analysis of the RADIANT-4 study
Yao JC, Oh DY, Qian JM, Park YS, Herbst F, Ridolfi A, Izquierdo M, Ito T, Jia LQ, Komoto I, Sriuranpong V, Shimada Y
OncoTargets and Therapy 2019, 12:1717-1728
Published Date: 28 February 2019
Effects of CYP2D6 and CYP3A5 polymorphisms on tamoxifen and its metabolites in Thai breast cancer patients
Charoenchokthavee W, Areepium N, Panomvana D, Sriuranpong V
Breast Cancer: Targets and Therapy 2017, 9:249-256
Published Date: 15 April 2017
Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment
Charoenchokthavee W, Panomvana D, Sriuranpong V, Areepium N
Breast Cancer: Targets and Therapy 2016, 8:149-155
Published Date: 8 August 2016